About Abil Chempharma
Abil Chempharma is a Healthcare company based in India. Manufacturing, marketing, and exporting of APIs, intermediates, and finished formulations in the pharmaceutical sector. The company has 3 employees. Its Indian entity Abil Chempharma Private Limited reported revenue of ₹795 Cr. Abil Chempharma offers products and services including APIs and Finished Formulations. Its focus areas include Pharmaceuticals, Contract Manufacturing, Regulatory and Export Services and API Manufacturing.
Company details
Abil Chempharma was established in 2000 in Mumbai, India, and is engaged in the manufacturing, marketing, distribution, and export of active pharmaceutical ingredients, intermediates, and finished formulations. A strong presence has been built in both domestic and international markets, with products adhering to high international ethical standards and guidelines. Operations include contract manufacturing, new product development using advanced technology, and regulatory approvals, while serving clients across the globe through robust networks. Quality is maintained through GMP-certified facilities and compliance with global regulations, ensuring cost-effective delivery of innovative solutions.
- Headquarters India
- Employees 3
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Abil Chempharma Private Limited
- Date of Incorporation 18 Sep, 2002
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹795 Cr
FY 2025 · +6% YoY
- Net Profit₹18.09 Cr
FY 2025 · 2% margin
- EBITDA₹25.85 Cr
FY 2025 · 3% margin
- Employee Count3
Associated legal entities of Abil Chempharma
Abil Chempharma operates through Abil Chempharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Abil Chempharma Private Limited CIN U51397MH2002PTC137264 | Active | 18 Sep 2002 | Mumbai, Maharashtra | ₹795 Cr | 3 | 3 | View details |
Products & Services of Abil Chempharma
Abil Chempharma offers a comprehensive portfolio of products and services, including APIs and Finished Formulations.
Active pharmaceutical ingredients are manufactured and supplied by Abil Chempharma for domestic and international markets.
Finished formulations are produced and exported by Abil Chempharma, covering areas like oncology and dermatology products.
Board of directors of Abil Chempharma Private Limited (Abil Chempharma)
Abil Chempharma Private Limited is the primary company behind Abil Chempharma. The board of Abil Chempharma Private Limited currently have 3 directors; the longest-serving is Tejas Champaklal Shah, appointed in 2012. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tejas Champaklal Shah DIN 01499314 | Director | 01 Dec 2012 | 13 yrs 10 mo | Abil Chempharma Private Limited |
| Sanket Jatin Gandhi DIN 10282271 | Director | 21 Aug 2023 | 3 yrs 2 mo | Abil Chempharma Private Limited |
| Jayesh Ajit Paurana DIN 11651706 | Additional Director | 08 Apr 2026 | 6 mo | Abil Chempharma Private Limited |
Financials of Abil Chempharma
Figures of Abil Chempharma Private Limited, the primary company behind Abil Chempharma, for FY 2025. Revenue was ₹795 Cr (+6% year on year). Net profit was ₹18.09 Cr (2% margin). EBITDA was ₹25.85 Cr (3% margin). Revenue has grown at a compounded annual rate of +7% over three years and +22% over five years.
- ₹795 CrRevenue · FY 2025 · +6% YoY
- ₹18.09 CrNet profit · 2% margin
- ₹25.85 CrEBITDA · 3% margin
- ₹27.3 LakhPaid-up capital
- 3Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Abil Chempharma Private Limited are on its company page.
Detailed financial statements for Abil Chempharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Abil Chempharma
Abil Chempharma is headquartered in India.
Abil Chempharma has 3 employees.
The primary company behind Abil Chempharma, Abil Chempharma Private Limited, reported revenue of ₹795 Cr for FY 2025, up 6% year on year.
Abil Chempharma was established in 2000 in Mumbai, India, and is engaged in the manufacturing, marketing, distribution, and export of active pharmaceutical ingredients, intermediates, and finished formulations. A strong presence has been built in both domestic and international markets, with products adhering to high international ethical standards and guidelines. Operations include contract manufacturing, new product development using advanced technology, and regulatory approvals, while serving clients across the globe through robust networks. Quality is maintained through GMP-certified facilities and compliance with global regulations, ensuring cost-effective delivery of innovative solutions.
Abil Chempharma offers APIs and Finished Formulations.
Abil Chempharma operates through Abil Chempharma Private Limited.
The legal entities of Abil Chempharma currently have 3 directors, including Sanket Jatin Gandhi, Tejas Champaklal Shah, Jayesh Ajit Paurana.